APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Varicella-Zoster Immunoglobulin

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Human Varicella-Zoster Immunoglobulin Industry Growth and Trends Forecast to 2032

22 December 202592 pages

Choose your research edition.

Industry ResearchHuman Varicella-Zoster Immunoglobulin Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Varicella-Zoster Immunoglobulin Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Human Varicella-Zoster Immunoglobulin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Varicella-Zoster Immunoglobulin Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Varicella-Zoster Immunoglobulin Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Human Varicella-Zoster Immunoglobulin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Human Varicella-Zoster Immunoglobulin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Human Varicella-Zoster Immunoglobulin is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human Varicella-Zoster Immunoglobulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Human Varicella-Zoster Immunoglobulin include Aptevo Biotherapeutics Llc, Bio Products Laboratory, Cangene Biopharma, Kamada, Ki Biopharma Llc, MassBiologics, Salmedon and Saol Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Human Varicella-Zoster Immunoglobulin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Human Varicella-Zoster Immunoglobulin market size, estimates, and forecasts are presented in terms of sales volume (units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Human Varicella-Zoster Immunoglobulin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Human Varicella-Zoster Immunoglobulin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Human Varicella-Zoster Immunoglobulin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Human Varicella-Zoster Immunoglobulin Market by Company

Aptevo Biotherapeutics Llc

Bio Products Laboratory

Cangene Biopharma

Kamada

Ki Biopharma Llc

MassBiologics

Salmedon

Saol Therapeutics

Human Varicella-Zoster Immunoglobulin Segment by Type

Freeze-dried Powder

Injection

Human Varicella-Zoster Immunoglobulin Segment by Application

Hospital

Clinic

Human Varicella-Zoster Immunoglobulin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Varicella-Zoster Immunoglobulin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Varicella-Zoster Immunoglobulin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Varicella-Zoster Immunoglobulin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Human Varicella-Zoster Immunoglobulin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Human Varicella-Zoster Immunoglobulin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Freeze-dried Powder Table 2. Major Company of Injection Table 3. Global Human Varicella-Zoster Immunoglobulin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Human Varicella-Zoster Immunoglobulin Sales by Type (2021-2026) & (units) Table 5. Global Human Varicella-Zoster Immunoglobulin Sales Market Share in Volume by Type (2021-2026) Table 6. Global Human Varicella-Zoster Immunoglobulin Sales by Type (2021-2026) & (US$ Million) Table 7. Global Human Varicella-Zoster Immunoglobulin Sales Market Share in Value by Type (2021-2026) Table 8. Global Human Varicella-Zoster Immunoglobulin Price by Type (2021-2026) & (US$/unit) Table 9. Global Human Varicella-Zoster Immunoglobulin Sales by Type (2027-2032) & (units) Table 10. Global Human Varicella-Zoster Immunoglobulin Sales Market Share in Volume by Type (2027-2032) Table 11. Global Human Varicella-Zoster Immunoglobulin Sales by Type (2027-2032) & (US$ Million) Table 12. Global Human Varicella-Zoster Immunoglobulin Sales Market Share in Value by Type (2027-2032) Table 13. Global Human Varicella-Zoster Immunoglobulin Price by Type (2027-2032) & (US$/unit) Table 14. North America Human Varicella-Zoster Immunoglobulin Sales by Type (2021-2026) & (units) Table 15. North America Human Varicella-Zoster Immunoglobulin Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Human Varicella-Zoster Immunoglobulin Sales by Type (2021-2026) & (units) Table 17. Europe Human Varicella-Zoster Immunoglobulin Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Human Varicella-Zoster Immunoglobulin Sales by Type (2021-2026) & (units) Table 19. Asia-Pacific Human Varicella-Zoster Immunoglobulin Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Human Varicella-Zoster Immunoglobulin Sales by Type (2021-2026) & (units) Table 21. Latin America Human Varicella-Zoster Immunoglobulin Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Human Varicella-Zoster Immunoglobulin Sales by Type (2021-2026) & (units) Table 23. Middle East and Africa Human Varicella-Zoster Immunoglobulin Sales by Type (2021-2026) & (US$ Million) Table 24. Human Varicella-Zoster Immunoglobulin Industry Trends Table 25. Human Varicella-Zoster Immunoglobulin Industry Drivers Table 26. Human Varicella-Zoster Immunoglobulin Industry Opportunities and Challenges Table 27. Human Varicella-Zoster Immunoglobulin Industry Restraints Table 28. Global Human Varicella-Zoster Immunoglobulin Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Human Varicella-Zoster Immunoglobulin Revenue Market Share by Company (2021-2026) Table 30. Global Human Varicella-Zoster Immunoglobulin Sales by Company (2021-2026) & (units) Table 31. Global Human Varicella-Zoster Immunoglobulin Sales Share by Company (2021-2026) Table 32. Global Human Varicella-Zoster Immunoglobulin Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Human Varicella-Zoster Immunoglobulin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Human Varicella-Zoster Immunoglobulin Major Company Production Sites and Headquarters Table 35. Global Human Varicella-Zoster Immunoglobulin Company, Product Type & Application Table 36. Global Human Varicella-Zoster Immunoglobulin Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Human Varicella-Zoster Immunoglobulin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Human Varicella-Zoster Immunoglobulin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Human Varicella-Zoster Immunoglobulin Sales by Region (2021-2026) & (units) Table 41. Global Human Varicella-Zoster Immunoglobulin Sales Market Share in Volume by Region (2021-2026) Table 42. Global Human Varicella-Zoster Immunoglobulin Sales by Region (2021-2026) & (US$ Million) Table 43. Global Human Varicella-Zoster Immunoglobulin Sales Market Share in Value by Region (2021-2026) Table 44. Global Human Varicella-Zoster Immunoglobulin Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Human Varicella-Zoster Immunoglobulin Sales by Region (2027-2032) & (units) Table 46. Global Human Varicella-Zoster Immunoglobulin Sales Market Share in Volume by Region (2027-2032) Table 47. Global Human Varicella-Zoster Immunoglobulin Sales by Region (2027-2032) & (US$ Million) Table 48. Global Human Varicella-Zoster Immunoglobulin Sales Market Share in Value by Region (2027-2032) Table 49. Global Human Varicella-Zoster Immunoglobulin Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Human Varicella-Zoster Immunoglobulin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Human Varicella-Zoster Immunoglobulin Sales by Application (2021-2026) & (units) Table 52. Global Human Varicella-Zoster Immunoglobulin Sales Market Share in Volume by Application (2021-2026) Table 53. Global Human Varicella-Zoster Immunoglobulin Sales by Application (2021-2026) & (US$ Million) Table 54. Global Human Varicella-Zoster Immunoglobulin Sales Market Share in Value by Application (2021-2026) Table 55. Global Human Varicella-Zoster Immunoglobulin Price by Application (2021-2026) & (US$/unit) Table 56. Global Human Varicella-Zoster Immunoglobulin Sales by Application (2027-2032) & (units) Table 57. Global Human Varicella-Zoster Immunoglobulin Sales Market Share in Volume by Application (2027-2032) Table 58. Global Human Varicella-Zoster Immunoglobulin Sales by Application (2027-2032) & (US$ Million) Table 59. Global Human Varicella-Zoster Immunoglobulin Sales Market Share in Value by Application (2027-2032) Table 60. Global Human Varicella-Zoster Immunoglobulin Price by Application (2027-2032) & (US$/unit) Table 61. North America Human Varicella-Zoster Immunoglobulin Sales by Application (2021-2026) & (units) Table 62. North America Human Varicella-Zoster Immunoglobulin Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Human Varicella-Zoster Immunoglobulin Sales by Application (2021-2026) & (units) Table 64. Europe Human Varicella-Zoster Immunoglobulin Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Human Varicella-Zoster Immunoglobulin Sales by Application (2021-2026) & (units) Table 66. Asia-Pacific Human Varicella-Zoster Immunoglobulin Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Human Varicella-Zoster Immunoglobulin Sales by Application (2021-2026) & (units) Table 68. Latin America Human Varicella-Zoster Immunoglobulin Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Human Varicella-Zoster Immunoglobulin Sales by Application (2021-2026) & (units) Table 70. Middle East and Africa Human Varicella-Zoster Immunoglobulin Sales by Application (2021-2026) & (US$ Million) Table 71. Aptevo Biotherapeutics Llc Company Information Table 72. Aptevo Biotherapeutics Llc Business Overview Table 73. Aptevo Biotherapeutics Llc Human Varicella-Zoster Immunoglobulin Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Aptevo Biotherapeutics Llc Human Varicella-Zoster Immunoglobulin Product Portfolio Table 75. Aptevo Biotherapeutics Llc Recent Development Table 76. Bio Products Laboratory Company Information Table 77. Bio Products Laboratory Business Overview Table 78. Bio Products Laboratory Human Varicella-Zoster Immunoglobulin Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Bio Products Laboratory Human Varicella-Zoster Immunoglobulin Product Portfolio Table 80. Bio Products Laboratory Recent Development Table 81. Cangene Biopharma Company Information Table 82. Cangene Biopharma Business Overview Table 83. Cangene Biopharma Human Varicella-Zoster Immunoglobulin Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Cangene Biopharma Human Varicella-Zoster Immunoglobulin Product Portfolio Table 85. Cangene Biopharma Recent Development Table 86. Kamada Company Information Table 87. Kamada Business Overview Table 88. Kamada Human Varicella-Zoster Immunoglobulin Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Kamada Human Varicella-Zoster Immunoglobulin Product Portfolio Table 90. Kamada Recent Development Table 91. Ki Biopharma Llc Company Information Table 92. Ki Biopharma Llc Business Overview Table 93. Ki Biopharma Llc Human Varicella-Zoster Immunoglobulin Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Ki Biopharma Llc Human Varicella-Zoster Immunoglobulin Product Portfolio Table 95. Ki Biopharma Llc Recent Development Table 96. MassBiologics Company Information Table 97. MassBiologics Business Overview Table 98. MassBiologics Human Varicella-Zoster Immunoglobulin Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. MassBiologics Human Varicella-Zoster Immunoglobulin Product Portfolio Table 100. MassBiologics Recent Development Table 101. Salmedon Company Information Table 102. Salmedon Business Overview Table 103. Salmedon Human Varicella-Zoster Immunoglobulin Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Salmedon Human Varicella-Zoster Immunoglobulin Product Portfolio Table 105. Salmedon Recent Development Table 106. Saol Therapeutics Company Information Table 107. Saol Therapeutics Business Overview Table 108. Saol Therapeutics Human Varicella-Zoster Immunoglobulin Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Saol Therapeutics Human Varicella-Zoster Immunoglobulin Product Portfolio Table 110. Saol Therapeutics Recent Development Table 111. North America Human Varicella-Zoster Immunoglobulin Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 112. North America Human Varicella-Zoster Immunoglobulin Sales by Country (2021-2026) & (units) Table 113. North America Human Varicella-Zoster Immunoglobulin Sales Market Share by Country (2021-2026) Table 114. North America Human Varicella-Zoster Immunoglobulin Sales Forecast by Country (2027-2032) & (units) Table 115. North America Human Varicella-Zoster Immunoglobulin Sales Market Share Forecast by Country (2027-2032) Table 116. North America Human Varicella-Zoster Immunoglobulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. North America Human Varicella-Zoster Immunoglobulin Market Size by Country (2021-2026) & (US$ Million) Table 118. North America Human Varicella-Zoster Immunoglobulin Market Share by Country (2021-2026) Table 119. North America Human Varicella-Zoster Immunoglobulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. North America Human Varicella-Zoster Immunoglobulin Market Share Forecast by Country (2027-2032) Table 121. Europe Human Varicella-Zoster Immunoglobulin Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 122. Europe Human Varicella-Zoster Immunoglobulin Sales by Country (2021-2026) & (units) Table 123. Europe Human Varicella-Zoster Immunoglobulin Sales Market Share by Country (2021-2026) Table 124. Europe Human Varicella-Zoster Immunoglobulin Sales Forecast by Country (2027-2032) & (units) Table 125. Europe Human Varicella-Zoster Immunoglobulin Sales Market Share Forecast by Country (2027-2032) Table 126. Europe Human Varicella-Zoster Immunoglobulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Europe Human Varicella-Zoster Immunoglobulin Market Size by Country (2021-2026) & (US$ Million) Table 128. Europe Human Varicella-Zoster Immunoglobulin Market Share by Country (2021-2026) Table 129. Europe Human Varicella-Zoster Immunoglobulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Europe Human Varicella-Zoster Immunoglobulin Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Human Varicella-Zoster Immunoglobulin Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Human Varicella-Zoster Immunoglobulin Sales by Country (2021-2026) & (units) Table 133. Asia-Pacific Human Varicella-Zoster Immunoglobulin Sales Market Share by Country (2021-2026) Table 134. Asia-Pacific Human Varicella-Zoster Immunoglobulin Sales Forecast by Country (2027-2032) & (units) Table 135. Asia-Pacific Human Varicella-Zoster Immunoglobulin Sales Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Human Varicella-Zoster Immunoglobulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Human Varicella-Zoster Immunoglobulin Market Size by Country (2021-2026) & (US$ Million) Table 138. Asia-Pacific Human Varicella-Zoster Immunoglobulin Market Share by Country (2021-2026) Table 139. Asia-Pacific Human Varicella-Zoster Immunoglobulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Asia-Pacific Human Varicella-Zoster Immunoglobulin Market Share Forecast by Country (2027-2032) Table 141. Latin America Human Varicella-Zoster Immunoglobulin Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 142. Latin America Human Varicella-Zoster Immunoglobulin Sales by Country (2021-2026) & (units) Table 143. Latin America Human Varicella-Zoster Immunoglobulin Sales Market Share by Country (2021-2026) Table 144. Latin America Human Varicella-Zoster Immunoglobulin Sales Forecast by Country (2027-2032) & (units) Table 145. Latin America Human Varicella-Zoster Immunoglobulin Sales Market Share Forecast by Country (2027-2032) Table 146. Latin America Human Varicella-Zoster Immunoglobulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Latin America Human Varicella-Zoster Immunoglobulin Market Size by Country (2021-2026) & (US$ Million) Table 148. Latin America Human Varicella-Zoster Immunoglobulin Market Share by Country (2021-2026) Table 149. Latin America Human Varicella-Zoster Immunoglobulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Latin America Human Varicella-Zoster Immunoglobulin Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Human Varicella-Zoster Immunoglobulin Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Human Varicella-Zoster Immunoglobulin Sales by Country (2021-2026) & (units) Table 153. Middle East and Africa Human Varicella-Zoster Immunoglobulin Sales Market Share by Country (2021-2026) Table 154. Middle East and Africa Human Varicella-Zoster Immunoglobulin Sales Forecast by Country (2027-2032) & (units) Table 155. Middle East and Africa Human Varicella-Zoster Immunoglobulin Sales Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Human Varicella-Zoster Immunoglobulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Human Varicella-Zoster Immunoglobulin Market Size by Country (2021-2026) & (US$ Million) Table 158. Middle East and Africa Human Varicella-Zoster Immunoglobulin Market Share by Country (2021-2026) Table 159. Middle East and Africa Human Varicella-Zoster Immunoglobulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Middle East and Africa Human Varicella-Zoster Immunoglobulin Market Share Forecast by Country (2027-2032) Table 161. Key Raw Materials Table 162. Raw Materials Key Suppliers Table 163. Human Varicella-Zoster Immunoglobulin Distributors List Table 164. Human Varicella-Zoster Immunoglobulin Customers List Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. Human Varicella-Zoster Immunoglobulin Image Figure 2. Global Human Varicella-Zoster Immunoglobulin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Varicella-Zoster Immunoglobulin Market Size (2021-2032) & (US$ Million) Figure 4. Global Human Varicella-Zoster Immunoglobulin Sales (2021-2032) & (units) Figure 5. Freeze-dried Powder Image Figure 6. Global Freeze-dried Powder Sales YoY Growth (2021-2032) & (units) Figure 7. Injection Image Figure 8. Global Injection Sales YoY Growth (2021-2032) & (units) Figure 9. Global Human Varicella-Zoster Immunoglobulin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Human Varicella-Zoster Immunoglobulin Market Share by Type 2025 VS 2032 Figure 11. North America Human Varicella-Zoster Immunoglobulin Sales Market Share in Volume by Type in 2025 Figure 12. North America Human Varicella-Zoster Immunoglobulin Sales Market Share in Value by Type in 2025 Figure 13. Europe Human Varicella-Zoster Immunoglobulin Sales Market Share in Volume by Type in 2025 Figure 14. Europe Human Varicella-Zoster Immunoglobulin Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Human Varicella-Zoster Immunoglobulin Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Human Varicella-Zoster Immunoglobulin Sales Market Share in Value by Type in 2025 Figure 17. Latin America Human Varicella-Zoster Immunoglobulin Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Human Varicella-Zoster Immunoglobulin Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Human Varicella-Zoster Immunoglobulin Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Human Varicella-Zoster Immunoglobulin Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Human Varicella-Zoster Immunoglobulin Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (units) Figure 27. Global Human Varicella-Zoster Immunoglobulin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Human Varicella-Zoster Immunoglobulin Market Share by Application 2025 VS 2032 Figure 29. North America Human Varicella-Zoster Immunoglobulin Sales Market Share in Volume by Application in 2025 Figure 30. North America Human Varicella-Zoster Immunoglobulin Sales Market Share in Value by Application in 2025 Figure 31. Europe Human Varicella-Zoster Immunoglobulin Sales Market Share in Volume by Application in 2025 Figure 32. Europe Human Varicella-Zoster Immunoglobulin Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Human Varicella-Zoster Immunoglobulin Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Human Varicella-Zoster Immunoglobulin Sales Market Share in Value by Application in 2025 Figure 35. Latin America Human Varicella-Zoster Immunoglobulin Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Human Varicella-Zoster Immunoglobulin Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Human Varicella-Zoster Immunoglobulin Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Human Varicella-Zoster Immunoglobulin Sales Market Share in Value by Application in 2025 Figure 39. North America Human Varicella-Zoster Immunoglobulin Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 40. North America Human Varicella-Zoster Immunoglobulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Human Varicella-Zoster Immunoglobulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Human Varicella-Zoster Immunoglobulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Human Varicella-Zoster Immunoglobulin Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 44. Europe Human Varicella-Zoster Immunoglobulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Human Varicella-Zoster Immunoglobulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Human Varicella-Zoster Immunoglobulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Human Varicella-Zoster Immunoglobulin Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 48. Asia-Pacific Human Varicella-Zoster Immunoglobulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Human Varicella-Zoster Immunoglobulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Human Varicella-Zoster Immunoglobulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Human Varicella-Zoster Immunoglobulin Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 52. Latin America Human Varicella-Zoster Immunoglobulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Human Varicella-Zoster Immunoglobulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Human Varicella-Zoster Immunoglobulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Human Varicella-Zoster Immunoglobulin Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 56. Middle East and Africa Human Varicella-Zoster Immunoglobulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Human Varicella-Zoster Immunoglobulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Human Varicella-Zoster Immunoglobulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Human Varicella-Zoster Immunoglobulin Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Human Varicella-Zoster Immunoglobulin Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Freeze-dried Powder
  • Injection
Applications
  • Hospital
  • Clinic
Companies covered
  • Aptevo Biotherapeutics Llc
  • Bio Products Laboratory
  • Cangene Biopharma
  • Kamada
  • Ki Biopharma Llc
  • MassBiologics
  • Salmedon
  • Saol Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Human Varicella-Zoster Immunoglobulin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Human Varicella-Zoster Immunoglobulin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Human Varicella-Zoster Immunoglobulin Market by Type
  6. 1.3.1 Freeze-dried Powder
  7. 1.3.2 Injection
  8. 1.4 Global Human Varicella-Zoster Immunoglobulin Market Size by Type
  9. 1.4.1 Global Human Varicella-Zoster Immunoglobulin Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Human Varicella-Zoster Immunoglobulin Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Human Varicella-Zoster Immunoglobulin Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Human Varicella-Zoster Immunoglobulin Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Human Varicella-Zoster Immunoglobulin Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Human Varicella-Zoster Immunoglobulin Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Human Varicella-Zoster Immunoglobulin Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Human Varicella-Zoster Immunoglobulin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Human Varicella-Zoster Immunoglobulin Industry Trends
  2. 2.2 Human Varicella-Zoster Immunoglobulin Industry Drivers
  3. 2.3 Human Varicella-Zoster Immunoglobulin Industry Opportunities and Challenges
  4. 2.4 Human Varicella-Zoster Immunoglobulin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Human Varicella-Zoster Immunoglobulin Revenue (2021-2026)
  2. 3.2 Global Top Players by Human Varicella-Zoster Immunoglobulin Sales (2021-2026)
  3. 3.3 Global Top Players by Human Varicella-Zoster Immunoglobulin Price (2021-2026)
  4. 3.4 Global Human Varicella-Zoster Immunoglobulin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Human Varicella-Zoster Immunoglobulin Major Company Production Sites & Headquarters
  6. 3.6 Global Human Varicella-Zoster Immunoglobulin Company, Product Type & Application
  7. 3.7 Global Human Varicella-Zoster Immunoglobulin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Human Varicella-Zoster Immunoglobulin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Human Varicella-Zoster Immunoglobulin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Human Varicella-Zoster Immunoglobulin Tier 1, Tier 2, and Tier 3
4 Human Varicella-Zoster Immunoglobulin Regional Status and Outlook
  1. 4.1 Global Human Varicella-Zoster Immunoglobulin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Human Varicella-Zoster Immunoglobulin Historic Market Size by Region
  3. 4.2.1 Global Human Varicella-Zoster Immunoglobulin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Human Varicella-Zoster Immunoglobulin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Human Varicella-Zoster Immunoglobulin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Human Varicella-Zoster Immunoglobulin Forecasted Market Size by Region
  7. 4.3.1 Global Human Varicella-Zoster Immunoglobulin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Human Varicella-Zoster Immunoglobulin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Human Varicella-Zoster Immunoglobulin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Human Varicella-Zoster Immunoglobulin by Application
  1. 5.1 Human Varicella-Zoster Immunoglobulin Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Human Varicella-Zoster Immunoglobulin Market Size by Application
  5. 5.2.1 Global Human Varicella-Zoster Immunoglobulin Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Human Varicella-Zoster Immunoglobulin Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Human Varicella-Zoster Immunoglobulin Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Human Varicella-Zoster Immunoglobulin Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Human Varicella-Zoster Immunoglobulin Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Human Varicella-Zoster Immunoglobulin Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Human Varicella-Zoster Immunoglobulin Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Human Varicella-Zoster Immunoglobulin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Aptevo Biotherapeutics Llc
  2. 6.1.1 Aptevo Biotherapeutics Llc Company Information
  3. 6.1.2 Aptevo Biotherapeutics Llc Business Overview
  4. 6.1.3 Aptevo Biotherapeutics Llc Human Varicella-Zoster Immunoglobulin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Aptevo Biotherapeutics Llc Human Varicella-Zoster Immunoglobulin Product Portfolio
  6. 6.1.5 Aptevo Biotherapeutics Llc Recent Developments
  7. 6.2 Bio Products Laboratory
  8. 6.2.1 Bio Products Laboratory Company Information
  9. 6.2.2 Bio Products Laboratory Business Overview
  10. 6.2.3 Bio Products Laboratory Human Varicella-Zoster Immunoglobulin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Bio Products Laboratory Human Varicella-Zoster Immunoglobulin Product Portfolio
  12. 6.2.5 Bio Products Laboratory Recent Developments
  13. 6.3 Cangene Biopharma
  14. 6.3.1 Cangene Biopharma Company Information
  15. 6.3.2 Cangene Biopharma Business Overview
  16. 6.3.3 Cangene Biopharma Human Varicella-Zoster Immunoglobulin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Cangene Biopharma Human Varicella-Zoster Immunoglobulin Product Portfolio
  18. 6.3.5 Cangene Biopharma Recent Developments
  19. 6.4 Kamada
  20. 6.4.1 Kamada Company Information
  21. 6.4.2 Kamada Business Overview
  22. 6.4.3 Kamada Human Varicella-Zoster Immunoglobulin Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Kamada Human Varicella-Zoster Immunoglobulin Product Portfolio
  24. 6.4.5 Kamada Recent Developments
  25. 6.5 Ki Biopharma Llc
  26. 6.5.1 Ki Biopharma Llc Company Information
  27. 6.5.2 Ki Biopharma Llc Business Overview
  28. 6.5.3 Ki Biopharma Llc Human Varicella-Zoster Immunoglobulin Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Ki Biopharma Llc Human Varicella-Zoster Immunoglobulin Product Portfolio
  30. 6.5.5 Ki Biopharma Llc Recent Developments
  31. 6.6 MassBiologics
  32. 6.6.1 MassBiologics Company Information
  33. 6.6.2 MassBiologics Business Overview
  34. 6.6.3 MassBiologics Human Varicella-Zoster Immunoglobulin Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 MassBiologics Human Varicella-Zoster Immunoglobulin Product Portfolio
  36. 6.6.5 MassBiologics Recent Developments
  37. 6.7 Salmedon
  38. 6.7.1 Salmedon Company Information
  39. 6.7.2 Salmedon Business Overview
  40. 6.7.3 Salmedon Human Varicella-Zoster Immunoglobulin Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Salmedon Human Varicella-Zoster Immunoglobulin Product Portfolio
  42. 6.7.5 Salmedon Recent Developments
  43. 6.8 Saol Therapeutics
  44. 6.8.1 Saol Therapeutics Company Information
  45. 6.8.2 Saol Therapeutics Business Overview
  46. 6.8.3 Saol Therapeutics Human Varicella-Zoster Immunoglobulin Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Saol Therapeutics Human Varicella-Zoster Immunoglobulin Product Portfolio
  48. 6.8.5 Saol Therapeutics Recent Developments
7 North America by Country
  1. 7.1 North America Human Varicella-Zoster Immunoglobulin Sales by Country
  2. 7.1.1 North America Human Varicella-Zoster Immunoglobulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Human Varicella-Zoster Immunoglobulin Sales by Country (2021-2026)
  4. 7.1.3 North America Human Varicella-Zoster Immunoglobulin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Human Varicella-Zoster Immunoglobulin Market Size by Country
  6. 7.2.1 North America Human Varicella-Zoster Immunoglobulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Human Varicella-Zoster Immunoglobulin Market Size by Country (2021-2026)
  8. 7.2.3 North America Human Varicella-Zoster Immunoglobulin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Human Varicella-Zoster Immunoglobulin Sales by Country
  2. 8.1.1 Europe Human Varicella-Zoster Immunoglobulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Human Varicella-Zoster Immunoglobulin Sales by Country (2021-2026)
  4. 8.1.3 Europe Human Varicella-Zoster Immunoglobulin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Human Varicella-Zoster Immunoglobulin Market Size by Country
  6. 8.2.1 Europe Human Varicella-Zoster Immunoglobulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Human Varicella-Zoster Immunoglobulin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Human Varicella-Zoster Immunoglobulin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Human Varicella-Zoster Immunoglobulin Sales by Country
  2. 9.1.1 Asia-Pacific Human Varicella-Zoster Immunoglobulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Human Varicella-Zoster Immunoglobulin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Human Varicella-Zoster Immunoglobulin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Human Varicella-Zoster Immunoglobulin Market Size by Country
  6. 9.2.1 Asia-Pacific Human Varicella-Zoster Immunoglobulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Human Varicella-Zoster Immunoglobulin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Human Varicella-Zoster Immunoglobulin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Human Varicella-Zoster Immunoglobulin Sales by Country
  2. 10.1.1 South America Human Varicella-Zoster Immunoglobulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Human Varicella-Zoster Immunoglobulin Sales by Country (2021-2026)
  4. 10.1.3 South America Human Varicella-Zoster Immunoglobulin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Human Varicella-Zoster Immunoglobulin Market Size by Country
  6. 10.2.1 South America Human Varicella-Zoster Immunoglobulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Human Varicella-Zoster Immunoglobulin Market Size by Country (2021-2026)
  8. 10.2.3 South America Human Varicella-Zoster Immunoglobulin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Human Varicella-Zoster Immunoglobulin Sales by Country
  2. 11.1.1 Middle East and Africa Human Varicella-Zoster Immunoglobulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Human Varicella-Zoster Immunoglobulin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Human Varicella-Zoster Immunoglobulin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Human Varicella-Zoster Immunoglobulin Market Size by Country
  6. 11.2.1 Middle East and Africa Human Varicella-Zoster Immunoglobulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Human Varicella-Zoster Immunoglobulin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Human Varicella-Zoster Immunoglobulin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Human Varicella-Zoster Immunoglobulin Value Chain Analysis
  2. 12.1.1 Human Varicella-Zoster Immunoglobulin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Human Varicella-Zoster Immunoglobulin Production Mode & Process
  7. 12.2 Human Varicella-Zoster Immunoglobulin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Human Varicella-Zoster Immunoglobulin Distributors
  10. 12.2.3 Human Varicella-Zoster Immunoglobulin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst